MedTrace Logo

Telederm and Bullous Pemphigoid

NCT04728854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2023-10-13

No results posted yet for this study

Summary

The purpose of the study is to improve the quality of future clinical trials in bullous pemphigoid (BP), the investigators will monitor repeated measurement data from patients with BP on standard-of-care treatments at four week intervals for four months.

Conditions

  • Bullous Pemphigoid

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Ron Feldman, MD, PhD · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2023-10-06
Completion
2023-10-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728854 on ClinicalTrials.gov